Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03760718 · ClinicalTrials.gov registry record · Early Phase 1
Chloroprocaine Lavage to Improve Outcomes Related to Operative Cesarean Delivery
A Early Phase 1 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 15
- Enrollment target
NCT03760718 is a Early Phase 1 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 15 participants.
The verdict
NCT03760718, a Early Phase 1 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The long term objective is to show that intraperitoneal chloroprocaine can be used an alternative option to avoid general anesthesia during cesarean delivery, to alleviate mother's discomfort from surgical pain, reduce complications, and improve the birth experience. The objectives in this study are to determine the amount of chloroprocaine that is absorbed into the blood in order to create a plasma concentration time profile and to determine the incidence of side effects to help guide selection of an appropriate concentration for future study.
Interventions
- DRUG Preservative free 1% Chloroprocaine
- DRUG Preservative free 2% Chloroprocaine
- DRUG Preservative free 3% Chloroprocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-09-30 |
| Est. Completion | 2021-12-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03760718
The ClinicalTrials.gov registry entry for NCT03760718 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Preservative free 1% Chloroprocaine is the first listed.
NCT03760718 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03760718 about?
NCT03760718 is a clinical study titled "Chloroprocaine Lavage to Improve Outcomes Related to Operative Cesarean Delivery". The long term objective is to show that intraperitoneal chloroprocaine can be used an alternative option to avoid general anesthesia during cesarean delivery, to alleviate mother's discomfort from surgical pain, reduce complications, and improve the birth experience. The objectives in this study are...
What is the current status of trial NCT03760718?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 15 participants. The study started on 2019-09-30. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT03760718?
The interventions under investigation include: Preservative free 1% Chloroprocaine (DRUG), Preservative free 2% Chloroprocaine (DRUG), Preservative free 3% Chloroprocaine (DRUG).
Who is sponsoring clinical trial NCT03760718?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.